Insider trades

Mark N. Lampert, Officer of Kymera Therapeutics KYMR, has filed 35 purchases and 25 sales on the open market. Over the past 12 months that comes to a net sale of $236.6M. The latest trade was on 06/26.

Mark N. Lampert

SEE REMARKS and Footnotes
First filing
23/01/19
Trades
183 trades
Buys / sales
35 / 25
12-month net buying
−$236.6M
Last trade
06/26

Trading activity

Transactions

Trade type
KYMR
Open-market sale06/2606/261,630,658 sh4 trades$106.50avg.$173,665,077No record
MLTX
Open-market sale03/3104/023,750,000 sh3 trades$16.79avg.$62,962,500−78.3%
Open-market sale25/08/0525/08/07156 sh3 trades$1.88avg.$293.28−0.0%
KYMR
Open-market buy25/06/3025/07/01317,167 sh3 trades$44.00avg.$13,955,348+875.1%
Open-market sale25/05/1625/05/20392,723 sh2 trades$27.10avg.$10,642,793.3−23.7%
Open-market sale25/01/2425/01/28650,717 sh4 trades$26.10avg.$16,983,713.7No record
Open-market sale24/10/2924/10/311,000,000 sh3 trades$14.30avg.$14,300,000−85.0%
MLTX
Open-market sale24/10/0424/10/082,000,000 sh3 trades$50.00avg.$100,000,000−60.8%
ELDN
Open-market buy24/05/0924/05/131,927,937 sh3 tradesNo stated valueNo stated valueNo record
Open-market sale23/12/1823/12/2017,161,278 sh3 trades$12.45avg.$213,657,911.1−100.0%
Open-market buy23/11/15–23/11/1623/11/171,227,301 sh6 trades$5.09avg.$6,248,888.1No record
KYMR
Open-market buy23/11/02–23/11/0323/11/06414,105 sh6 trades$12.80avg.$5,300,590.77No record
Open-market buy23/11/0223/11/03783,709 sh3 trades$3.60avg.$2,821,352.4No record
OLMA
Open-market buy23/09/1223/09/141,505,932 sh3 trades$9.84avg.$14,818,370.88No record
ELDN
Open-market buy23/05/0523/05/091,978,932 sh3 tradesNo stated valueNo stated valueNo record
KYMR
Open-market buy23/01/11–23/01/1223/01/1341,007 sh4 trades$30.51avg.$1,251,210.18+2.2%
Open-market buy23/01/05–23/01/0623/01/0922,249 sh4 trades$18.91avg.$420,823.02+1.4%